London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal antibody that ...

Dr. Ransom is a graduate of the University of Iowa College of Medicine (1962) and was certified by the American Board of Allergy and Immunology in 1974. He is a Fellow of the American College of ...

Occasional patients with chronic sinusitis who use intranasal ... He has been a practicing physician for 30 years. Ransom JH. Sinusitis: Diagnosis and Treatment. MedGenMed 1(1), 1999 [formerly ...

Sinusitis is a condition that occurs when sinuses become inflamed due to infections Read this article to know what might be ...

China approves GSK's Nucala for chronic rhinosinusitis with nasal polyps, adding to its existing uses in asthma and other ...

GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...

IntroductionThe demand for ENT (Ears, Nose, and Throat) treatment solutions is rising significantly due to the increasing ...

Chronic sinusitis is a condition where inflammation ... When sinusitis does not respond to treatment, your doctor may recommend surgery to remove a polyp or nasal tissue.

(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study.

Sinusitis can usually be diagnosed by examination and tests are performed for confirmation. It is considered chronic if it lasts for 12 weeks or longer. Treatable by a medical professional ...